As of 2024-10-13, the Relative Valuation of Fate Therapeutics Inc (FATE) is (37.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.09 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -1301.0%.
The range of the Relative Valuation is (36.26) - (37.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 38.1x | 25.9x |
| Forward P/E multiples | 21.6x - 24.4x | 22.2x |
| Fair Price | (36.26) - (37.59) | (37.11) |
| Upside | -1273.5% - -1316.5% | -1301.0% |
| Date | P/E |
| 2024-10-11 | -2.00 |
| 2024-10-10 | -1.91 |
| 2024-10-09 | -1.95 |
| 2024-10-08 | -1.99 |
| 2024-10-07 | -1.98 |
| 2024-10-04 | -2.09 |
| 2024-10-03 | -2.02 |
| 2024-10-02 | -2.08 |
| 2024-10-01 | -2.17 |
| 2024-09-30 | -2.27 |
| 2024-09-27 | -2.31 |
| 2024-09-26 | -2.27 |
| 2024-09-25 | -2.24 |
| 2024-09-24 | -2.24 |
| 2024-09-23 | -2.36 |
| 2024-09-20 | -2.51 |
| 2024-09-19 | -2.59 |
| 2024-09-18 | -2.51 |
| 2024-09-17 | -2.59 |
| 2024-09-16 | -2.57 |
| 2024-09-13 | -2.61 |
| 2024-09-12 | -2.42 |
| 2024-09-11 | -2.51 |
| 2024-09-10 | -2.48 |
| 2024-09-09 | -2.24 |
| 2024-09-06 | -2.20 |
| 2024-09-05 | -2.30 |
| 2024-09-04 | -2.28 |
| 2024-09-03 | -2.24 |
| 2024-08-30 | -2.38 |
| 2024-08-29 | -2.29 |
| 2024-08-28 | -2.27 |
| 2024-08-27 | -2.33 |
| 2024-08-26 | -2.51 |
| 2024-08-23 | -2.49 |
| 2024-08-22 | -2.44 |
| 2024-08-21 | -2.53 |
| 2024-08-20 | -2.38 |
| 2024-08-19 | -2.35 |
| 2024-08-16 | -2.20 |
| 2024-08-15 | -2.20 |
| 2024-08-14 | -2.12 |
| 2024-08-13 | -2.16 |
| 2024-08-12 | -2.16 |
| 2024-08-09 | -2.18 |
| 2024-08-08 | -2.35 |
| 2024-08-07 | -2.58 |
| 2024-08-06 | -2.78 |
| 2024-08-05 | -2.72 |
| 2024-08-02 | -3.00 |